

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 8.06037169 |
| 2 | myofibril assembly (GO:0030239) | 6.64089416 |
| 3 | sarcomere organization (GO:0045214) | 6.54795395 |
| 4 | cardiac muscle contraction (GO:0060048) | 6.52775597 |
| 5 | actin-myosin filament sliding (GO:0033275) | 6.26653649 |
| 6 | muscle filament sliding (GO:0030049) | 6.26653649 |
| 7 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.99442017 |
| 8 | cardiac muscle hypertrophy (GO:0003300) | 5.90231597 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.87627976 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.73541177 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.64346422 |
| 12 | striated muscle hypertrophy (GO:0014897) | 5.60262373 |
| 13 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.47353723 |
| 14 | cardiac muscle cell development (GO:0055013) | 5.46591727 |
| 15 | regulation of relaxation of muscle (GO:1901077) | 5.43540532 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.42365776 |
| 17 | actin-mediated cell contraction (GO:0070252) | 5.42301652 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.39904797 |
| 19 | muscle tissue morphogenesis (GO:0060415) | 5.34932325 |
| 20 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.33955003 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.31129543 |
| 22 | cardiac cell development (GO:0055006) | 5.17548999 |
| 23 | cell communication by electrical coupling (GO:0010644) | 5.05645816 |
| 24 | regulation of sarcomere organization (GO:0060297) | 5.03785740 |
| 25 | adult heart development (GO:0007512) | 4.91219742 |
| 26 | muscle hypertrophy (GO:0014896) | 4.90604471 |
| 27 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.89055303 |
| 28 | regulation of the force of heart contraction (GO:0002026) | 4.88372025 |
| 29 | actomyosin structure organization (GO:0031032) | 4.86210798 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 4.83074882 |
| 31 | striated muscle contraction (GO:0006941) | 4.81149064 |
| 32 | heart contraction (GO:0060047) | 4.79456639 |
| 33 | heart process (GO:0003015) | 4.79456639 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 4.71005207 |
| 35 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.65079864 |
| 36 | regulation of cardioblast differentiation (GO:0051890) | 4.60450268 |
| 37 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.47877957 |
| 38 | cardiac ventricle formation (GO:0003211) | 4.41525070 |
| 39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.37270446 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 4.31910449 |
| 41 | regulation of cell communication by electrical coupling (GO:0010649) | 4.24514426 |
| 42 | adrenergic receptor signaling pathway (GO:0071875) | 4.22155411 |
| 43 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.22054861 |
| 44 | regulation of membrane repolarization (GO:0060306) | 4.18771451 |
| 45 | heart trabecula formation (GO:0060347) | 4.18375640 |
| 46 | sodium ion export (GO:0071436) | 4.14960561 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.13533840 |
| 48 | actin filament-based movement (GO:0030048) | 4.13008229 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11034444 |
| 50 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.07660764 |
| 51 | tricarboxylic acid cycle (GO:0006099) | 4.04717577 |
| 52 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.01773045 |
| 53 | regulation of ATP catabolic process (GO:1903289) | 3.98344337 |
| 54 | negative regulation of protein localization to cell surface (GO:2000009) | 3.91400336 |
| 55 | relaxation of cardiac muscle (GO:0055119) | 3.90931519 |
| 56 | cardiac muscle adaptation (GO:0014887) | 3.90593448 |
| 57 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.90593448 |
| 58 | muscle hypertrophy in response to stress (GO:0003299) | 3.90593448 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.85845339 |
| 60 | cardiac muscle cell action potential (GO:0086001) | 3.82684411 |
| 61 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.79175150 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.77089104 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.77089104 |
| 64 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.72528127 |
| 65 | cardiac conduction (GO:0061337) | 3.71705856 |
| 66 | relaxation of muscle (GO:0090075) | 3.69832533 |
| 67 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.68531659 |
| 68 | regulation of cardiac muscle contraction (GO:0055117) | 3.63663949 |
| 69 | cellular response to epinephrine stimulus (GO:0071872) | 3.60604129 |
| 70 | regulation of heart rate (GO:0002027) | 3.60282414 |
| 71 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.58463559 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.53991694 |
| 73 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.53789325 |
| 74 | response to epinephrine (GO:0071871) | 3.52359897 |
| 75 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.51984429 |
| 76 | negative regulation of hormone metabolic process (GO:0032351) | 3.50294474 |
| 77 | outflow tract septum morphogenesis (GO:0003148) | 3.49532765 |
| 78 | regulation of skeletal muscle contraction (GO:0014819) | 3.46105905 |
| 79 | positive regulation of heart rate (GO:0010460) | 3.44575133 |
| 80 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.44301447 |
| 81 | positive regulation of sodium ion transport (GO:0010765) | 3.43253629 |
| 82 | negative regulation of myotube differentiation (GO:0010832) | 3.39918116 |
| 83 | positive regulation of ATP catabolic process (GO:1903291) | 3.38918921 |
| 84 | positive regulation of ATPase activity (GO:0032781) | 3.38918921 |
| 85 | cardiac chamber formation (GO:0003207) | 3.38549472 |
| 86 | desmosome organization (GO:0002934) | 3.37957405 |
| 87 | regulation of heart contraction (GO:0008016) | 3.36843420 |
| 88 | positive regulation of heart contraction (GO:0045823) | 3.36313755 |
| 89 | response to caffeine (GO:0031000) | 3.35722592 |
| 90 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.35225207 |
| 91 | membrane repolarization during action potential (GO:0086011) | 3.34787107 |
| 92 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.28128960 |
| 93 | ventricular cardiac muscle cell development (GO:0055015) | 3.27937117 |
| 94 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.27799580 |
| 95 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.27452986 |
| 96 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.27452986 |
| 97 | plasma membrane repair (GO:0001778) | 3.25746512 |
| 98 | gap junction assembly (GO:0016264) | 3.24692783 |
| 99 | atrioventricular valve morphogenesis (GO:0003181) | 3.23827872 |
| 100 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.23475634 |
| 101 | detection of calcium ion (GO:0005513) | 3.22432045 |
| 102 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.21354523 |
| 103 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.20748400 |
| 104 | cardiac muscle tissue development (GO:0048738) | 3.19929473 |
| 105 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.18535652 |
| 106 | striated muscle cell development (GO:0055002) | 3.17117008 |
| 107 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.16585867 |
| 108 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15791786 |
| 109 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.14744622 |
| 110 | respiratory electron transport chain (GO:0022904) | 3.14092772 |
| 111 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.14000710 |
| 112 | regulation of muscle contraction (GO:0006937) | 3.13443426 |
| 113 | negative regulation of potassium ion transport (GO:0043267) | 3.13366597 |
| 114 | atrial septum morphogenesis (GO:0060413) | 3.08928592 |
| 115 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.07573912 |
| 116 | embryonic heart tube development (GO:0035050) | 3.06777474 |
| 117 | cellular sodium ion homeostasis (GO:0006883) | 3.06657474 |
| 118 | relaxation of smooth muscle (GO:0044557) | 3.06558144 |
| 119 | electron transport chain (GO:0022900) | 3.05995336 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05576255 |
| 121 | cardiac right ventricle morphogenesis (GO:0003215) | 3.04728124 |
| 122 | carnitine shuttle (GO:0006853) | 3.03747343 |
| 123 | positive regulation of heart growth (GO:0060421) | 3.00663680 |
| 124 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.99985709 |
| 125 | cellular component maintenance (GO:0043954) | 2.99777627 |
| 126 | membrane repolarization (GO:0086009) | 2.98921631 |
| 127 | regulation of ATPase activity (GO:0043462) | 2.97811704 |
| 128 | multicellular organismal signaling (GO:0035637) | 2.97762319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.36788714 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.81798968 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86252675 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73157888 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60007845 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.51033917 |
| 7 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41740858 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33371613 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33371613 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30930582 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.27427710 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.22475811 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22449101 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.14804339 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.12665983 |
| 16 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12168207 |
| 17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09544867 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07231701 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06901908 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01160790 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89113516 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80425397 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79028233 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76608556 |
| 25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73058978 |
| 26 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.72190891 |
| 27 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.72190891 |
| 28 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.70865385 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.66666820 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63089805 |
| 31 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.60187498 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58565527 |
| 33 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56626230 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.54378232 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53021347 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51284124 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50746382 |
| 38 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47421697 |
| 39 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44677601 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41520656 |
| 41 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39302932 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38015331 |
| 43 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37120371 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36591126 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36186139 |
| 46 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35551300 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35237661 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35087159 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34598532 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34461704 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33660053 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32596614 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32493609 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31350777 |
| 55 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30976543 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29461649 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28978260 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28893203 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27847490 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27579706 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26119478 |
| 62 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25622830 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25411977 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24363785 |
| 65 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.23474422 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22286619 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20482642 |
| 68 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20288474 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19633841 |
| 70 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19542588 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19250099 |
| 72 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19046205 |
| 73 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18658231 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18509808 |
| 75 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18353276 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18280213 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16516566 |
| 78 | * AR_19668381_ChIP-Seq_PC3_Human | 1.15010035 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14805942 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14621368 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14621368 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12320259 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11970028 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11888976 |
| 85 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11158509 |
| 86 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09466671 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09001812 |
| 88 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08054592 |
| 89 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07313557 |
| 90 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05965561 |
| 91 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05893500 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05798656 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05675269 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05619789 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04480772 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03951206 |
| 97 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03862431 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03534411 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02623631 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02552572 |
| 101 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01629521 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00972998 |
| 103 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00952902 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00894962 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00706524 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00648039 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00602469 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00542459 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00474793 |
| 110 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98559740 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97193690 |
| 112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97133381 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94627421 |
| 114 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94086309 |
| 115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94058148 |
| 116 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93524016 |
| 117 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.93101230 |
| 118 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92166407 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92049475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.02737097 |
| 2 | MP0004215_abnormal_myocardial_fiber | 4.27752824 |
| 3 | MP0004036_abnormal_muscle_relaxation | 4.20366199 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.14695017 |
| 5 | MP0000749_muscle_degeneration | 3.70799287 |
| 6 | MP0005330_cardiomyopathy | 3.45959127 |
| 7 | MP0002972_abnormal_cardiac_muscle | 3.35820022 |
| 8 | MP0000751_myopathy | 3.33942787 |
| 9 | MP0003646_muscle_fatigue | 3.03375704 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.00386705 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.86822568 |
| 12 | MP0004510_myositis | 2.76837577 |
| 13 | MP0004085_abnormal_heartbeat | 2.67960670 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.66711795 |
| 15 | MP0006138_congestive_heart_failure | 2.56762744 |
| 16 | MP0004484_altered_response_of | 2.53577389 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.43654206 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.38981184 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 2.38981184 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.37019509 |
| 21 | MP0002127_abnormal_cardiovascular_syste | 2.24512607 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.23909445 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 2.22497643 |
| 24 | MP0003122_maternal_imprinting | 2.18395522 |
| 25 | MP0003828_pulmonary_edema | 2.17204450 |
| 26 | MP0002106_abnormal_muscle_physiology | 1.80774490 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76643916 |
| 28 | MP0003880_abnormal_central_pattern | 1.70298402 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.66447777 |
| 30 | MP0005451_abnormal_body_composition | 1.64355732 |
| 31 | MP0002269_muscular_atrophy | 1.51092084 |
| 32 | MP0005369_muscle_phenotype | 1.46121604 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.43654282 |
| 34 | MP0003567_abnormal_fetal_cardiomyocyte | 1.37445522 |
| 35 | MP0002102_abnormal_ear_morphology | 1.36958442 |
| 36 | MP0005670_abnormal_white_adipose | 1.34601113 |
| 37 | MP0009745_abnormal_behavioral_response | 1.34257342 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.32228284 |
| 39 | MP0004233_abnormal_muscle_weight | 1.31918631 |
| 40 | MP0004130_abnormal_muscle_cell | 1.31911167 |
| 41 | MP0009046_muscle_twitch | 1.29178254 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.28676005 |
| 43 | MP0000747_muscle_weakness | 1.28494922 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.25397826 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.24099016 |
| 46 | MP0004272_abnormal_basement_membrane | 1.24049201 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.22385082 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.18889352 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.16018370 |
| 50 | MP0002736_abnormal_nociception_after | 1.11724289 |
| 51 | MP0002063_abnormal_learning/memory/cond | 1.10371456 |
| 52 | MP0002064_seizures | 1.09342850 |
| 53 | MP0000462_abnormal_digestive_system | 1.09294636 |
| 54 | MP0005623_abnormal_meninges_morphology | 1.07212632 |
| 55 | MP0001486_abnormal_startle_reflex | 1.06901231 |
| 56 | MP0001984_abnormal_olfaction | 1.06189062 |
| 57 | MP0003121_genomic_imprinting | 1.04879201 |
| 58 | MP0000266_abnormal_heart_morphology | 1.02717435 |
| 59 | MP0002272_abnormal_nervous_system | 0.98053792 |
| 60 | MP0002332_abnormal_exercise_endurance | 0.96757955 |
| 61 | MP0003123_paternal_imprinting | 0.96629889 |
| 62 | MP0002822_catalepsy | 0.93689189 |
| 63 | MP0002234_abnormal_pharynx_morphology | 0.93533328 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.93378156 |
| 65 | MP0003941_abnormal_skin_development | 0.93176084 |
| 66 | MP0000230_abnormal_systemic_arterial | 0.91088244 |
| 67 | MP0001661_extended_life_span | 0.90956298 |
| 68 | MP0002572_abnormal_emotion/affect_behav | 0.90863506 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 0.89884108 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.89305356 |
| 71 | MP0003878_abnormal_ear_physiology | 0.89305356 |
| 72 | MP0004270_analgesia | 0.87585629 |
| 73 | MP0005165_increased_susceptibility_to | 0.86566315 |
| 74 | MP0003045_fibrosis | 0.85484120 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.83452551 |
| 76 | MP0004924_abnormal_behavior | 0.80719739 |
| 77 | MP0005386_behavior/neurological_phenoty | 0.80719739 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 0.80587068 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.78744398 |
| 80 | MP0000579_abnormal_nail_morphology | 0.78111599 |
| 81 | MP0001440_abnormal_grooming_behavior | 0.77660105 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.76998769 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.76936358 |
| 84 | MP0002067_abnormal_sensory_capabilities | 0.76640591 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.75451164 |
| 86 | MP0003279_aneurysm | 0.74251869 |
| 87 | MP0002638_abnormal_pupillary_reflex | 0.74227671 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 0.70766537 |
| 89 | MP0008569_lethality_at_weaning | 0.68056845 |
| 90 | MP0002128_abnormal_blood_circulation | 0.67917991 |
| 91 | MP0001529_abnormal_vocalization | 0.67255778 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.63824225 |
| 93 | MP0002108_abnormal_muscle_morphology | 0.63799881 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.62744892 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.62007083 |
| 96 | MP0001784_abnormal_fluid_regulation | 0.61069612 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.59909694 |
| 98 | MP0005409_darkened_coat_color | 0.59528044 |
| 99 | MP0002925_abnormal_cardiovascular_devel | 0.59487741 |
| 100 | MP0001970_abnormal_pain_threshold | 0.58608980 |
| 101 | MP0005388_respiratory_system_phenotype | 0.58397322 |
| 102 | MP0002133_abnormal_respiratory_system | 0.58397322 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.53814493 |
| 104 | MP0000778_abnormal_nervous_system | 0.53148154 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.52948639 |
| 106 | MP0000534_abnormal_ureter_morphology | 0.52725778 |
| 107 | MP0002009_preneoplasia | 0.51260496 |
| 108 | MP0005171_absent_coat_pigmentation | 0.50499622 |
| 109 | MP0003984_embryonic_growth_retardation | 0.50328348 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.50163385 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.49269921 |
| 112 | MP0002184_abnormal_innervation | 0.48959690 |
| 113 | MP0005423_abnormal_somatic_nervous | 0.48475403 |
| 114 | MP0002733_abnormal_thermal_nociception | 0.48069080 |
| 115 | MP0004858_abnormal_nervous_system | 0.47951519 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.47915646 |
| 117 | MP0000516_abnormal_urinary_system | 0.47915646 |
| 118 | MP0005187_abnormal_penis_morphology | 0.47855256 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.46921300 |
| 120 | MP0000566_synostosis | 0.45478829 |
| 121 | MP0000733_abnormal_muscle_development | 0.43218411 |
| 122 | MP0003634_abnormal_glial_cell | 0.42768396 |
| 123 | MP0001177_atelectasis | 0.40785685 |
| 124 | MP0003787_abnormal_imprinting | 0.40101945 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.39928929 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.39330324 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.39087803 |
| 128 | MP0006072_abnormal_retinal_apoptosis | 0.38288366 |
| 129 | MP0003690_abnormal_glial_cell | 0.37953411 |
| 130 | MP0005503_abnormal_tendon_morphology | 0.37434045 |
| 131 | MP0010678_abnormal_skin_adnexa | 0.36776901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.16429177 |
| 2 | Atrial fibrillation (HP:0005110) | 6.64588575 |
| 3 | Ventricular tachycardia (HP:0004756) | 6.31909597 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 6.24500394 |
| 5 | Supraventricular tachycardia (HP:0004755) | 5.99805996 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.98690462 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.88404511 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.85147690 |
| 9 | Syncope (HP:0001279) | 5.41569636 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.30294027 |
| 11 | Exercise-induced myalgia (HP:0003738) | 5.07115325 |
| 12 | Lipoatrophy (HP:0100578) | 4.95410529 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.88586927 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.87313733 |
| 15 | Subaortic stenosis (HP:0001682) | 4.87313733 |
| 16 | Prolonged QT interval (HP:0001657) | 4.78427543 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.77599998 |
| 18 | Ventricular arrhythmia (HP:0004308) | 4.61589129 |
| 19 | Ventricular fibrillation (HP:0001663) | 4.09840587 |
| 20 | Congenital malformation of the right heart (HP:0011723) | 4.01922943 |
| 21 | Double outlet right ventricle (HP:0001719) | 4.01922943 |
| 22 | Dilated cardiomyopathy (HP:0001644) | 3.94064136 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.92567444 |
| 24 | Bundle branch block (HP:0011710) | 3.77693253 |
| 25 | Abnormal EKG (HP:0003115) | 3.75606411 |
| 26 | Palpitations (HP:0001962) | 3.71572959 |
| 27 | Myoglobinuria (HP:0002913) | 3.67908462 |
| 28 | Left ventricular hypertrophy (HP:0001712) | 3.42828921 |
| 29 | Heart block (HP:0012722) | 3.41580786 |
| 30 | Hypoplastic left heart (HP:0004383) | 3.37094184 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.36322981 |
| 32 | Atrioventricular block (HP:0001678) | 3.17118833 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 3.16121276 |
| 34 | Pheochromocytoma (HP:0002666) | 3.01883043 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 2.99609419 |
| 36 | Patent foramen ovale (HP:0001655) | 2.98818028 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.89241441 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87951541 |
| 39 | Palmoplantar keratoderma (HP:0000982) | 2.77908680 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.77766176 |
| 41 | Steppage gait (HP:0003376) | 2.76404502 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.68654014 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.63549229 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.58740958 |
| 45 | Hypoplastic heart (HP:0001961) | 2.58675954 |
| 46 | Focal motor seizures (HP:0011153) | 2.51339493 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.48511524 |
| 48 | Rhabdomyolysis (HP:0003201) | 2.46208236 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.46133941 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.44138041 |
| 51 | Abnormality of the foot musculature (HP:0001436) | 2.30778949 |
| 52 | Diaphragmatic weakness (HP:0009113) | 2.27715194 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.26288765 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.23863907 |
| 55 | Acute encephalopathy (HP:0006846) | 2.23653832 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.23640910 |
| 57 | Hip contracture (HP:0003273) | 2.22643985 |
| 58 | Exercise intolerance (HP:0003546) | 2.16294067 |
| 59 | Preauricular pit (HP:0004467) | 2.15886367 |
| 60 | Periauricular skin pits (HP:0100277) | 2.15886367 |
| 61 | Myotonia (HP:0002486) | 2.15708411 |
| 62 | Increased CSF lactate (HP:0002490) | 2.14107435 |
| 63 | Abnormality of glycolysis (HP:0004366) | 2.11647797 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.11647797 |
| 65 | Neoplasm of the adrenal gland (HP:0100631) | 2.11350695 |
| 66 | Bradycardia (HP:0001662) | 2.10593881 |
| 67 | Neck muscle weakness (HP:0000467) | 2.10538478 |
| 68 | Hepatic necrosis (HP:0002605) | 2.06102837 |
| 69 | Myokymia (HP:0002411) | 2.04237124 |
| 70 | Foot dorsiflexor weakness (HP:0009027) | 2.03161006 |
| 71 | Partial duplication of thumb phalanx (HP:0009944) | 2.01130732 |
| 72 | Sudden cardiac death (HP:0001645) | 2.00991423 |
| 73 | Transposition of the great arteries (HP:0001669) | 1.90673693 |
| 74 | Abnormal connection of the cardiac segments (HP:0011545) | 1.90673693 |
| 75 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.90673693 |
| 76 | Hepatocellular necrosis (HP:0001404) | 1.88399729 |
| 77 | Congestive heart failure (HP:0001635) | 1.86893943 |
| 78 | Limited hip movement (HP:0008800) | 1.85751336 |
| 79 | Areflexia of lower limbs (HP:0002522) | 1.82475820 |
| 80 | EMG: neuropathic changes (HP:0003445) | 1.81275875 |
| 81 | Generalized muscle weakness (HP:0003324) | 1.80313486 |
| 82 | Muscle stiffness (HP:0003552) | 1.79704373 |
| 83 | Truncus arteriosus (HP:0001660) | 1.79687093 |
| 84 | Hamartoma of the eye (HP:0010568) | 1.73240651 |
| 85 | Abnormality of the salivary glands (HP:0010286) | 1.72932085 |
| 86 | Pulmonary artery stenosis (HP:0004415) | 1.70230801 |
| 87 | Childhood onset (HP:0011463) | 1.69652876 |
| 88 | Partial duplication of the phalanx of hand (HP:0009999) | 1.69523524 |
| 89 | Skin pits (HP:0100276) | 1.68844298 |
| 90 | Muscular dystrophy (HP:0003560) | 1.67224296 |
| 91 | Toxemia of pregnancy (HP:0100603) | 1.65519878 |
| 92 | Bicuspid aortic valve (HP:0001647) | 1.63340020 |
| 93 | Cerebral edema (HP:0002181) | 1.62109566 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61858579 |
| 95 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.61259971 |
| 96 | Respiratory failure (HP:0002878) | 1.60853743 |
| 97 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.60752736 |
| 98 | Aplasia of the phalanges of the hand (HP:0009802) | 1.60752736 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 1.60752736 |
| 100 | Type 1 muscle fiber predominance (HP:0003803) | 1.59661261 |
| 101 | Abnormality of the ischium (HP:0003174) | 1.58710069 |
| 102 | Central scotoma (HP:0000603) | 1.55590721 |
| 103 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.55493339 |
| 104 | Papillary thyroid carcinoma (HP:0002895) | 1.55267726 |
| 105 | Anxiety (HP:0000739) | 1.54543766 |
| 106 | Cerebral hemorrhage (HP:0001342) | 1.54475436 |
| 107 | Focal seizures (HP:0007359) | 1.53034844 |
| 108 | Dysmetric saccades (HP:0000641) | 1.51077583 |
| 109 | Difficulty running (HP:0009046) | 1.50422200 |
| 110 | Lactic acidosis (HP:0003128) | 1.50370677 |
| 111 | Coarctation of aorta (HP:0001680) | 1.49140421 |
| 112 | Febrile seizures (HP:0002373) | 1.49104434 |
| 113 | Ketoacidosis (HP:0001993) | 1.47360491 |
| 114 | X-linked dominant inheritance (HP:0001423) | 1.47035831 |
| 115 | Resting tremor (HP:0002322) | 1.46908962 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.46765021 |
| 117 | Lymphangioma (HP:0100764) | 1.46294638 |
| 118 | Abnormality of the tricuspid valve (HP:0001702) | 1.46038280 |
| 119 | Vitreoretinal degeneration (HP:0000655) | 1.38849955 |
| 120 | Maternal diabetes (HP:0009800) | 1.34928857 |
| 121 | Anomalous pulmonary venous return (HP:0010772) | 1.34291280 |
| 122 | Neonatal hypoglycemia (HP:0001998) | 1.34198594 |
| 123 | Skin nodule (HP:0200036) | 1.32947650 |
| 124 | Aneurysm (HP:0002617) | 1.32394155 |
| 125 | Late onset (HP:0003584) | 1.32227567 |
| 126 | Scapular winging (HP:0003691) | 1.29652528 |
| 127 | Visceral angiomatosis (HP:0100761) | 1.28551796 |
| 128 | Arterial tortuosity (HP:0005116) | 1.28426677 |
| 129 | Preaxial foot polydactyly (HP:0001841) | 1.28045554 |
| 130 | Hyperglycemia (HP:0003074) | 1.25521165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.32448880 |
| 2 | MYLK | 4.45912835 |
| 3 | STK24 | 3.74323340 |
| 4 | FLT3 | 2.74408907 |
| 5 | ZAK | 2.45634990 |
| 6 | LMTK2 | 2.43691161 |
| 7 | DMPK | 2.39676534 |
| 8 | MUSK | 2.28473729 |
| 9 | PIK3CA | 2.20311450 |
| 10 | NTRK3 | 2.18739722 |
| 11 | PHKG2 | 2.16438352 |
| 12 | PHKG1 | 2.16438352 |
| 13 | EPHA4 | 2.08893142 |
| 14 | PKN2 | 1.90047004 |
| 15 | STK38L | 1.87435734 |
| 16 | TIE1 | 1.79548705 |
| 17 | CDC42BPA | 1.76179081 |
| 18 | PDK3 | 1.61973777 |
| 19 | PDK4 | 1.61973777 |
| 20 | LATS1 | 1.50614335 |
| 21 | TNIK | 1.42122373 |
| 22 | TTN | 1.35005880 |
| 23 | PRKD3 | 1.30534640 |
| 24 | LIMK1 | 1.29687468 |
| 25 | PTK2B | 1.28870439 |
| 26 | PAK3 | 1.25653210 |
| 27 | MAP3K4 | 1.23895813 |
| 28 | FRK | 1.23480209 |
| 29 | CAMK2D | 1.19978097 |
| 30 | MINK1 | 1.19738504 |
| 31 | ILK | 1.17618170 |
| 32 | ROCK1 | 1.16479182 |
| 33 | WNK4 | 1.12421772 |
| 34 | GRK7 | 1.11511866 |
| 35 | NEK9 | 1.10249400 |
| 36 | NEK1 | 1.09871333 |
| 37 | CAMK1 | 1.09572310 |
| 38 | FGFR2 | 1.09548606 |
| 39 | WNK1 | 1.08510654 |
| 40 | CAMK2A | 1.05447247 |
| 41 | STK39 | 1.04207335 |
| 42 | TRPM7 | 1.03109807 |
| 43 | PRPF4B | 1.01064695 |
| 44 | MAP2K7 | 1.00305512 |
| 45 | MAP3K9 | 1.00065874 |
| 46 | INSRR | 0.95806877 |
| 47 | PINK1 | 0.95250759 |
| 48 | PLK2 | 0.94696002 |
| 49 | STK38 | 0.94253412 |
| 50 | EPHB2 | 0.91955633 |
| 51 | PDK2 | 0.89374046 |
| 52 | MAP2K4 | 0.85555129 |
| 53 | PRKD1 | 0.84769582 |
| 54 | DAPK3 | 0.82184512 |
| 55 | AKT3 | 0.82129431 |
| 56 | MAP3K7 | 0.80815857 |
| 57 | RIPK1 | 0.80742074 |
| 58 | BCR | 0.80575497 |
| 59 | PRKCE | 0.78997184 |
| 60 | SGK2 | 0.76950591 |
| 61 | PDGFRA | 0.74806910 |
| 62 | EPHA3 | 0.74466043 |
| 63 | FER | 0.70351825 |
| 64 | STK4 | 0.69648766 |
| 65 | CASK | 0.69179332 |
| 66 | NTRK2 | 0.68958358 |
| 67 | MAPK13 | 0.67926210 |
| 68 | ROCK2 | 0.66955559 |
| 69 | MAP3K6 | 0.65436700 |
| 70 | MAPKAPK3 | 0.63987561 |
| 71 | NUAK1 | 0.62832221 |
| 72 | MAPK12 | 0.61701325 |
| 73 | PAK6 | 0.60889005 |
| 74 | MAPK7 | 0.60494736 |
| 75 | SGK494 | 0.60381476 |
| 76 | SGK223 | 0.60381476 |
| 77 | KSR1 | 0.60313838 |
| 78 | PKN1 | 0.59060861 |
| 79 | SGK3 | 0.54349620 |
| 80 | CAMK4 | 0.54276925 |
| 81 | PRKG1 | 0.54143905 |
| 82 | KSR2 | 0.54011262 |
| 83 | PRKCH | 0.53353430 |
| 84 | UHMK1 | 0.53315828 |
| 85 | PRKACA | 0.52927965 |
| 86 | CAMK2B | 0.52632381 |
| 87 | NLK | 0.51331355 |
| 88 | MAP3K5 | 0.51163490 |
| 89 | STK11 | 0.51043413 |
| 90 | PRKAA2 | 0.49777623 |
| 91 | CDK5 | 0.49496392 |
| 92 | SGK1 | 0.49362863 |
| 93 | CAMK2G | 0.48818242 |
| 94 | PRKACB | 0.48477200 |
| 95 | NTRK1 | 0.46226284 |
| 96 | DAPK2 | 0.45181853 |
| 97 | MAPK10 | 0.44727077 |
| 98 | STK3 | 0.43933245 |
| 99 | FGFR3 | 0.43282954 |
| 100 | ARAF | 0.42492834 |
| 101 | MAP3K2 | 0.41993782 |
| 102 | PRKCQ | 0.41731234 |
| 103 | FGFR1 | 0.41648644 |
| 104 | PRKAA1 | 0.41598811 |
| 105 | MAP3K12 | 0.40370416 |
| 106 | LATS2 | 0.39660520 |
| 107 | MARK1 | 0.38380437 |
| 108 | MET | 0.37508341 |
| 109 | PRKCG | 0.37441151 |
| 110 | GRK5 | 0.36883568 |
| 111 | BMPR2 | 0.34282942 |
| 112 | RET | 0.31176672 |
| 113 | PRKACG | 0.30939323 |
| 114 | TESK1 | 0.30093550 |
| 115 | MAP2K1 | 0.30077435 |
| 116 | PDGFRB | 0.29870943 |
| 117 | NEK6 | 0.29168308 |
| 118 | PDK1 | 0.28802568 |
| 119 | MAP3K13 | 0.28483410 |
| 120 | MARK3 | 0.28332122 |
| 121 | AKT2 | 0.28156867 |
| 122 | MAPK4 | 0.27253262 |
| 123 | ERBB3 | 0.26907899 |
| 124 | RPS6KA3 | 0.26430638 |
| 125 | CAMKK1 | 0.25213098 |
| 126 | DYRK1A | 0.21751465 |
| 127 | SCYL2 | 0.21672863 |
| 128 | PTK2 | 0.20987915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.81589211 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.94599100 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.69906662 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.59817930 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83586918 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.81974765 |
| 7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.57066878 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.44039430 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28011144 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11414766 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01641266 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91737007 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79418758 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75374169 |
| 15 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64920683 |
| 16 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.64909178 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60589170 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56355257 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.53911808 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45164823 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43179830 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40377380 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.37137179 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.33881090 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.33867983 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33751792 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.30275122 |
| 28 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.28743008 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28488789 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.25735895 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.22850130 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22090165 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21355612 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13800979 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13607679 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09837224 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08224938 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07290764 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04460038 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 1.04231077 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02488544 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 0.98471942 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92046607 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91627834 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90675322 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89860516 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88133784 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.86368899 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86315458 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85983328 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83748693 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80539173 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80338131 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.80209509 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.80159065 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.78412602 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77513872 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.77319429 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75283103 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73988621 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73872022 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.72429288 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.71898107 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71554745 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68815351 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67847954 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66255892 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63634403 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58265899 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58077580 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57698674 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56977629 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55757413 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54787272 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.54506421 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54005573 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53424679 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52960323 |
| 79 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52933028 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52355312 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.51703228 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49672888 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49512593 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47685155 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47466653 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46801859 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46577778 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46159547 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45274715 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45029889 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44812856 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44564903 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44450757 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43748013 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43658088 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42774477 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40518280 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40500578 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40242257 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40076412 |
| 101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39874998 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39655608 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38867589 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38420495 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38172087 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36354278 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35960699 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34962943 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.34778546 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34461170 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34244787 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33997877 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33617460 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33191380 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32339605 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32291183 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32218215 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.30879157 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28096424 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27702201 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27670708 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27586978 |

